European researchers have designed two new vaccine candidates to fight the HIV virus. These have been developed within the EU-funded project EURONEUT 41 .

AIDS research has attempted many strategies to tackle the HIV virus infection. Now, a new type of vaccine developed within an EU-funded project, called EuroNeut-41 , is based on one of the envelope proteins of the HIV virus , called the gp41 protein.

HIV is still plaguing humanity with 35 million infected people worldwide. Antiretroviral drugs do slow down the progression of the disease but at a high cost and with long term toxicity.

We are all exposed to polluted air. Among main air pollutants are nitrogen oxides —the so-called ‘NOx ‘— and ozone , which cause irritation of respiratory tract and eyes, favouring cough, lung infections in children and asthma.

“Antibiotic resistance threatens a return to the pre-antibiotic era”. The World Health Organisation uses this strong expression when referring to a phenomenon that is rapidly spreading: the increasing resistance of microorganisms to antimicrobial medicines, such as antibiotics .

November 18 th is the annual European Antibiotic Awareness Day . Its purpose is to highlight the increase of bacterial resistance to antibiotics on the continent .

Patients affected by a bacterial infection can usually be treated with an antibiotic. But sometimes a resistant bacterial strain is causing the infection .

Nowadays, doctors treat patients with broad spectrum antibiotics without testing. But if they want to test they can send the bacteria away to a laboratory. This microbiology laboratory will test sensitivities to antibiotics for them.